Han, O.; Bromma, K.; Palmerley, N.; Bido, A.T.; Monica, M.; Alhussan, A.; Howard, P.L.; Brolo, A.G.; Beckham, W.; Alexander, A.S.;
et al. Nanotechnology Driven Cancer Chemoradiation: Exploiting the Full Potential of Radiotherapy with a Unique Combination of Gold Nanoparticles and Bleomycin. Pharmaceutics 2022, 14, 233.
https://doi.org/10.3390/pharmaceutics14020233
AMA Style
Han O, Bromma K, Palmerley N, Bido AT, Monica M, Alhussan A, Howard PL, Brolo AG, Beckham W, Alexander AS,
et al. Nanotechnology Driven Cancer Chemoradiation: Exploiting the Full Potential of Radiotherapy with a Unique Combination of Gold Nanoparticles and Bleomycin. Pharmaceutics. 2022; 14(2):233.
https://doi.org/10.3390/pharmaceutics14020233
Chicago/Turabian Style
Han, Ocean, Kyle Bromma, Nicholas Palmerley, Ariadne T. Bido, Mesa Monica, Abdulaziz Alhussan, Perry L. Howard, Alexandre G. Brolo, Wayne Beckham, Abraham S. Alexander,
and et al. 2022. "Nanotechnology Driven Cancer Chemoradiation: Exploiting the Full Potential of Radiotherapy with a Unique Combination of Gold Nanoparticles and Bleomycin" Pharmaceutics 14, no. 2: 233.
https://doi.org/10.3390/pharmaceutics14020233
APA Style
Han, O., Bromma, K., Palmerley, N., Bido, A. T., Monica, M., Alhussan, A., Howard, P. L., Brolo, A. G., Beckham, W., Alexander, A. S., & Chithrani, D. B.
(2022). Nanotechnology Driven Cancer Chemoradiation: Exploiting the Full Potential of Radiotherapy with a Unique Combination of Gold Nanoparticles and Bleomycin. Pharmaceutics, 14(2), 233.
https://doi.org/10.3390/pharmaceutics14020233
